PharmAust publishes encouraging trial results, and picks new CEO
// Dr Michael Thurn is the new CEO, and trial results also suggest suppression in motor neurone disease progression…
// Dr Michael Thurn is the new CEO, and trial results also suggest suppression in motor neurone disease progression…
Sign up our newsletter to get update information, news and free insight.